|2.90||-0.031 / -1.06%|
Data as of 3:59pm ET
|2.88||-0.02 / -0.69%|
The 3 analysts offering 12-month price forecasts for Pluristem Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.50. The median estimate represents a +72.41% increase from the last price of 2.90.
The current consensus among 3 polled investment analysts is to Buy stock in Pluristem Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.